ClinicalTrials.Veeva

Menu

Replace Glycemic Load and Satiety Study

Pennington Biomedical Research Center logo

Pennington Biomedical Research Center

Status and phase

Completed
Phase 1

Conditions

Glycemic Index
Glucose Blood

Treatments

Other: Medium GL 76
Other: Medium GL 68
Other: High GL 107
Other: Low GL 48

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT01516333
PBRC 26026

Details and patient eligibility

About

The study is to examine the effect of four diets differing in glycemic index and amount of carbohydrate on blood sugar and insulin and in hunger, satiety, and vigor.

Full description

The extent to which a food raises blood sugar after its consumption is ranked using the Glycemic Index (GI). Foods with a high GI are those taht cause a large and rapid rise in blood sugar while those with a low GI produce small fluctuations in blood sugar. It is believed that low GI foods are advantageous for health since the swings in blood sugar and insulin resistant or diabetic. Interestingly, some studies suggest that low GI food make you less hungry and that this may play an important role in body weight regulation.

Enrollment

26 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Body Mass index between 25-35 kg/m2
  • Fasting serum glucose
  • Fasting serum glucose < 125 mg/dl
  • Free of chronic disease
  • Willing to eat only the foods that are provided by the Center during the diet periods
  • Willing to abstain from the consumption of alcohol during the diet periods
  • Regularly cycling and willing not to become pregnant using birth control (abstinence, barrier methods, partner surgically sterile
  • Monophasic birth control (same dose each day)
  • Hormone replacement therapy
  • Post-menopausal (over 1 year without bleeding)
  • Have had partial hysterectomy over the age of 55
  • complete hysterectomy at any age

Exclusion criteria

  • Documented presence of atherosclerotic disease
  • Diabetes mellitus
  • Renal, hepatic, endocrine, gastrointestinal, hematological or other systemic disease
  • Body Mass Index <25 or > 35
  • History of drug or alcohol abuse in the last year
  • For women, pregnancy, breast feeding or postpartum < 6 months
  • History of depression or mental illness requiring treatment or medication within that last 6 months
  • Multiple food allergies or significant food preferences or restrictions that would interfere with diet adherence
  • Lifestyle or schedule incompatible with the study protocol
  • Planned continued use of dietary supplements through the study trial
  • Smoking or tobacco use

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

26 participants in 4 patient groups

Diet 1
Experimental group
Description:
High GI; High Carb; High GL
Treatment:
Other: High GL 107
Diet 2
Experimental group
Description:
High GI, Low Carb, Med GL
Treatment:
Other: Medium GL 76
Diet 3
Experimental group
Description:
Low GI, High Carb, Med GL
Treatment:
Other: Medium GL 68
Diet 4
Experimental group
Description:
Low GI, Low Carb, Low GL
Treatment:
Other: Low GL 48

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems